In the first study of its kind, research led by Canada's Centre for Addiction and Mental Health (CAMH) sheds light on the ...

Urges Congress Not to Give Up the Fight and to Act Swiftly to Advance Pharmacy Protections This YearWashington, DC, Dec. 18, ...

Theralase®'s lead drug, Ruvidar TM (TLD-1433), activated by the TLC-3200 Medical Laser System (“TLC-3200”) is currently under clinical investigation in Canada and the United States in a Phase II ...

Study II is a Phase 2, single arm, open label clinical study for patients diagnosed with BCG-Unresponsive NMIBC CIS designed in compliance with Health Canada and FDA guidance. The Study Procedure ...

is pleased to announce that it has launched a new Clinical Study Site ("CSS") for its bladder cancer clinical study; specifically, St. Joseph's Healthcare Hamilton (Hamilton, Ontario, Canada).

There were 2,434 new diagnosed cases of HIV in Canada in 2023, a 35% increase from the year before Fewer people are being diagnosed with and dying of HIV/AIDS around the world. But progress is ...

Initial efforts to track productivity tied to clinical pharmacy activities began in 2008. Early measures incorporated the number of orders verified relative to the number of hours worked ...

Canada is on a “clear path” to hit NATO’s defence spending target over the coming years, Prime Minister Justin Trudeau said, as pressure ramps up on Ottawa in the wake of the U.S. election.

The Canadian Association of Radiologists (CAR) is advocating for the implementation of Diagnostic Imaging (DI) Clinical Decision Support (CDS) Systems in Canada. Access to updated medical imaging ...

Health Canada has approved the first human trial for Neuralink’s clinical studies in the country. This marks the first time a clinical trial from the company will take place outside of the U.S. The ...

Nov 20 (Reuters) - Elon Musk's Neuralink said on Wednesday it has received approval to launch its first clinical trial in Canada for a device designed to give paralysed individuals the ability to ...